IWC
JAZZ icon

Integrated Wealth Concepts’s Jazz Pharmaceuticals JAZZ Stock Holding History

Integrated Wealth Concepts’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$425K Buy
1,762
+377
+27% +$82.6K ﹤0.01% 1764
2026
Q1 		$262K Buy
+1,385
New +$242K ﹤0.01% 1939
2025
Q3 		– Sell
-4,864
Closed -$516K – 2034
2025
Q2 		$516K Buy
+4,864
New +$528K 0.01% 1257

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Integrated Wealth Concepts's JAZZ Position: Q2 2026 in Review

Integrated Wealth Concepts increased its Jazz Pharmaceuticals (JAZZ) stake by 27% in Q2 2026, buying an estimated $82.6K and bringing the position to 1,762 shares worth $425K. The position accounts for ﹤0.01% of the portfolio, ranked #1764.

Integrated Wealth Concepts first reported a position in JAZZ in Q2 2025 and has held it in 3 quarters since. The position peaked at $516K in Q2 2025. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Integrated Wealth Concepts held 1,762 shares of Jazz Pharmaceuticals worth $425K as of Q2 2026.
  • Integrated Wealth Concepts bought 377 Jazz Pharmaceuticals shares in Q2 2026, an estimated $82.6K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #1764 holding.
  • Integrated Wealth Concepts first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • Integrated Wealth Concepts's Jazz Pharmaceuticals position peaked at $516K in Q2 2025.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.